Abrogation of antibody-induced arthritis in mice by a self-activating viridin prodrug and association with impaired neutrophil and endothelial cell function
Name
Yaffe_Abrogation.pdf
Size
1.05 MB
Format
Adobe PDF
Checksum (MD5)
36d8cc32c0c6fbd7be0024d2ee9decca
Author(s)
Stangenberg, Lars
Ellson, Chris
Cortez-Retamozo, Virna
Ortiz-Lopez, Adriana
Yuan, Hushan
Blois, Joseph
Smith, Ralph A.
Weissleder, Ralph
Benoist, Christophe
Mathis, Diane
Date Issued
July 2009
Journal
Arthritis & Rheumatism
Publisher
Wiley Blackwell
Citation
Stangenberg, Lars, Chris Ellson, Virna Cortez-Retamozo, Adriana Ortiz-Lopez, Hushan Yuan, Joseph Blois, Ralph A. Smith, et al. “Abrogation of Antibody-Induced Arthritis in Mice by a Self-Activating Viridin Prodrug and Association with Impaired Neutrophil and Endothelial Cell Function.” Arthritis Rheum 60, no. 8 (August 2009): 2314–2324.
Version
Author's final manuscript
Abstract
Objective:
To test a novel self-activating viridin (SAV) prodrug that slowly releases wortmannin, a potent phosphoinositide 3-kinase inhibitor, in a model of antibody-mediated inflammatory arthritis.
Methods:
The SAV prodrug was administered to K/BxN mice or to C57BL/6 (B6) mice that had been injected with K/BxN serum. Ankle thickness was measured, and histologic changes were scored after a 10-day disease course (serum-transfer arthritis). Protease activity was measured by a near-infrared imaging approach using a cleavable cathepsin–selective probe. Further near-infrared imaging techniques were used to analyze early changes in vascular permeability after serum injection, as well as neutrophil–endothelial cell interactions. Neutrophil functions were assessed using an oxidative burst assay as well as a degranulation assay.
Results:
SAV prevented ankle swelling in mice with serum-transfer arthritis in a dose-dependent manner. It also markedly reduced the extent of other features of arthritis, such as protease activity and histology scores for inflammation and joint erosion. Moreover, SAV was an effective therapeutic agent. The underlying mechanisms for the antiinflammatory activity were manifold. Endothelial permeability after serum injection was reduced, as was firm neutrophil attachment to endothelial cells. Endothelial cell activation by tumor necrosis factor α was impeded by SAV, as measured by the expression of vascular cell adhesion molecule. Crucial neutrophil functions, such as generation of reactive oxygen species and degranulation of protease-laden vesicles, were decreased by SAV administration.
Conclusion:
A novel SAV prodrug proved strongly antiinflammatory in a murine model of antibody-induced inflammatory arthritis. Its activity could be attributed, at least in part, to the inhibition of neutrophil and endothelial cell functions.
MIT Department
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1002/art.24704
